Search Results - "Capote, Ailem Rabasa"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells by Ahn, Jeonghyun, Xia, Tianli, Rabasa Capote, Ailem, Betancourt, Dillon, Barber, Glen N.

    Published in Cancer cell (14-05-2018)
    “…The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity by Schrand, Brett, Clark, Emily, Levay, Agata, Capote, Ailem Rabasa, Martinez, Olivier, Brenneman, Randall, Castro, Iris, Gilboa, Eli

    Published in Nature communications (22-08-2018)
    “…Uptake of tumor antigens by tumor-infiltrating dendritic cells is limiting step in the induction of tumor immunity, which can be mediated through Fc receptor…”
    Get full text
    Journal Article
  4. 4

    HER1-ECD vaccination dispenses with emulsification to elicit HER1-specific anti-proliferative effects by Alpízar, Yeranddy Aguiar, Ramírez, Belinda Sánchez, Hernández Fernández, Diana Rosa, Capote, Ailem Rabasa, Hidalgo, Greta Garrido, Pérez Rodríguez, Rolando, Fernández Molina, Luis Enrique

    Published in Human vaccines (01-03-2009)
    “…EGFR (HER1) highlights as one of the most relevant tumour associated antigen in epithelial malignant cells. Monoclonal antibodies and tyrosine kinase…”
    Get full text
    Journal Article
  5. 5

    Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine by Ramírez, Belinda Sánchez, Alpízar, Yeranddy Aguiar, Fernández, Diana Rosa Hernández, Hidalgo, Greta Garrido, Capote, Ailem Rabasa, Rodríguez, Rolando Pérez, Fernández, Luis Enrique

    Published in Vaccine (08-09-2008)
    “…Abstract Up to now clinical experiences focusing EGF receptor, an attractive target for cancer therapy, have been limited to passive therapies, suggesting that…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab’)2 Fragment in an Immunocompetent Mouse Model by Rabasa Capote, Ailem, González, Jorge Ernesto, Rodríguez-Vera, Leyanis, López, Armando, Sánchez Ramírez, Belinda, Garrido Hidalgo, Greta

    Published in ISRN pharmacology (01-01-2012)
    “…Immunocompetent mice, Fc receptor γ-chain deficient mice (Fcer1g−/−), and molecular tools as F(ab′)2 bivalent fragments appear as the most suitable biological…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its Fragment in an Immunocompetent Mouse Model by Rabasa Capote, Ailem, González, Jorge Ernesto, Rodríguez-Vera, Leyanis, López, Armando, Sánchez Ramírez, Belinda, Garrido Hidalgo, Greta

    Published in ISRN pharmacology (21-11-2012)
    “…Immunocompetent mice, Fc receptor γ -chain deficient mice (), and molecular tools as F(ab′) 2 bivalent fragments appear as the most suitable biological models…”
    Get full text
    Journal Article
  9. 9